Quarterly report · Q1
7459.TEDINET S100OYEC
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥838.3bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥3.29T | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥824.9bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥13.5bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥13.3bn | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥17.6bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥62.0bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥17.4bn | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥17.2bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥17.5bn | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥8.3bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥29.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.4bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥10.8bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥12.2bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥1.72T | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥1.71T | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥1.70T | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.06T | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥1.06T | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥659.0bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥649.1bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥645.5bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥218.8bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥243.2bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥39.39 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥140.14 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥44.99 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥36.94 | 2022-04-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥131.41 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥42.22 | 2021-04-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 31.4% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.0% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.1% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥913m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥913m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | ¥98m |
| jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥18.5bn |
| jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥18.5bn |
| jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1m |
| jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥692m |
| jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥276.2bn |
| jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥276.2bn |
| jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥94m |
| jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥6.5bn |
| jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥544.4bn |
| jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥543.6bn |
| jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥817m |
| jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥6.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥839.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥838.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥913m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥13.4bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥937m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥937m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | ¥169m |
| jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥18.1bn |
| jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥18.1bn |
| jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥0 |
| jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥734m |
| jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥269.7bn |
| jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥269.6bn |
| jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥90m |
| jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥7.0bn |
| jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥538.0bn |
| jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥537.1bn |
| jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥846m |
| jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥5.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-06-30 | ¥825.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-06-30 | ¥824.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥937m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-06-30 | ¥13.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 379
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 824877000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 824877000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 846000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E02632-000CosmeticsDailyNecessitiesAndOTCPharmaceuticalWholesaleBusinessReportableSegmentsMember | 90000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleBusinessReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 937000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -937000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 537988000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E02632-000CosmeticsDailyNecessitiesAndOTCPharmaceuticalWholesaleBusinessReportableSegmentsMember | 269689000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleBusinessReportableSegmentsMember | 18135000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 825814000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -937000000 | JPY |
| Net sales | Prior1YTDDuration | 824877000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 5373000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E02632-000CosmeticsDailyNecessitiesAndOTCPharmaceuticalWholesaleBusinessReportableSegmentsMember | 7005000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleBusinessReportableSegmentsMember | 734000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 13113000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | 169000000 | JPY |
| Operating income | Prior1YTDDuration | 13282000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 543628000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E02632-000CosmeticsDailyNecessitiesAndOTCPharmaceuticalWholesaleBusinessReportableSegmentsMember | 276152000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleBusinessReportableSegmentsMember | 18547000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 838328000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 838328000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 817000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E02632-000CosmeticsDailyNecessitiesAndOTCPharmaceuticalWholesaleBusinessReportableSegmentsMember | 94000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleBusinessReportableSegmentsMember | 1000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 913000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -913000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 544446000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E02632-000CosmeticsDailyNecessitiesAndOTCPharmaceuticalWholesaleBusinessReportableSegmentsMember | 276247000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleBusinessReportableSegmentsMember | 18548000000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 839242000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -913000000 | JPY |
| Net sales | CurrentYTDDuration | 838328000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 6211000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E02632-000CosmeticsDailyNecessitiesAndOTCPharmaceuticalWholesaleBusinessReportableSegmentsMember | 6514000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleBusinessReportableSegmentsMember | 692000000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 13417000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | 98000000 | JPY |
| Operating income | CurrentYTDDuration | 13516000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-08-10 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第114期第１四半期（自 2022年４月１日 至 2022年６月30日） |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |